1. P187 Secukinumab significantly decreased joint synovitis measured by Power Doppler ultrasonography in biologic-naive patients with active psoriatic arthritis: primary (12week) results from a randomised, placebo-controlled Phase 3 study. (26th April 2021) Authors: D'Agostino, Maria-Antonietta; Schett, Georg; Rodríguez, Alejandra López; Šenolt, Ladislav; Maldonado-Cocco, Jose; Burgos-Vargas, Ruben; Naredo, Esperanza; Carron, Philippe; Boers, Maarten; Duggan, Anne-Marie; Goyanka, Punit; Gaillez, Corine Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P253 Ultrasound demonstrates continued improvement in psoriatic arthritis synovitis and enthesitis with secukinumab: 52-week results from a Phase 3 study. (23rd April 2022) Authors: Conaghan, Philip G; D'Agostino, Maria A; Schett, Georg; Guerrero, Carlos; Hanova, Petra; Cazenave, Tomas; Stoenoiu, Maria S; Backhaus, Marina; Mouterde, Gaël; Boers, Maarten; Duggan, Anne-Marie; Goyanka, Punit; Gaillez, Corine Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE. (16th September 2021) Authors: D'Agostino, Maria Antonietta; Schett, Georg; López-Rdz, Alejandra; Šenolt, Ladislav; Fazekas, Katalin; Burgos-Vargas, Ruben; Maldonado-Cocco, Jose; Naredo, Esperanza; Carron, Philippe; Duggan, Anne-Marie; Goyanka, Punit; Boers, Maarten; Gaillez, Corine Journal: Rheumatology Issue: Volume 61:Number 5(2022) Page Start: 1867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗